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In spite of advances and refinements in surgical technique,
the development of post-traumatic arthritis following osteo-
chondral injury remains one of the major unsolved prob-
lems faced by orthopedic surgeons. Of particular interest is
the possibility that chondrocyte programmed cell death
(PCD), or ‘apoptosis’, contributes to the subsequent devel-
opment of post-traumatic arthritis1–5. Recent studies have
shown that inhibitors of caspases, key enzymes in the
apoptosis pathway, can block chondrocyte PCD in vitro4–7.
The goal of the presented study was to test the hypothesis
that short-term, intra-articular caspase inhibitor treatment
can limit chondrocyte PCD in vivo following acute osteo-
chondral injury. Adult New Zealand white rabbits underwent
experimental osteochondral injury. One group of rabbits
received daily intra-articular injections of the broad-
spectrum caspase inhibitor Z-VAD-fmk. A control group of
rabbits received daily intra-articular injections of vehicle
alone. After four days of treatment, the articular cartilage
was analyzed for chondrocyte PCD. Treatment with Z-VAD-
fmk resulted in a marked reduction in the percentage
of chondrocytes undergoing PCD compared to con-
trols [treated=7.4±1.8%; controls=32.5±8.6% (P<0.0001 by
student’s t-test)]. The degree of PCD inhibition was depen-
dent upon the distance from the site of injury, with levels of
PCD reduced to background levels in areas beyond 1 mm
from the drill hole. These results suggest that the intra-
articular administration of PCD inhibitors may be a useful
strategy for the treatment of osteochondral injury by limiting
the extent of articular chondrocyte loss due to apoptosis.
For these experiments, a drill with a cooled 2 mm bit
was used to create osteochondral injuries in the hind limb
femoral condyles of adult rabbits. The injuries were created
in the weight bearing portions of the condyles and pen-
etrated into the subchondral bone. Following surgery, five
animals received daily intra-articular injections of the cas-
pase inhibitor Z-VAD-fmk (100 µM in 0.1% DMSO, 0.5 cc;
Calbiochem, CA) delivered via an indwelling catheter. A
control group of five rabbits received daily intra-articular
injections of vehicle alone. The knee tissue was harvested
on post-injury day 4, decalcified in EDTA, embedded in
paraffin, and then sectioned in the sagittal plane at 5 µm
thickness for further analysis.
Chondrocyte apoptosis was quantified by TUNEL analy-
sis using the ApopTag® Direct in situ apoptosis detection
kit (Intergen, NY) with DAPI used as a counterstain.
Fluorescence images were captured using appropriate
filters with an Axiocam digital camera (Zeiss, NJ) at 1
megapixel resolution. Each captured field was subdivided
into three ‘Zones’ with Zone 1 encompassing the full
thickness of articular cartilage extending from 0 to 0.5 mm
away from the drill hole; Zone 2 extending from 0.5 to 1 mm
away from the drill hole; and Zone 3 extending from 1 to
1.5 mm away from the drill hole (Fig. 1). Semi-automated
data collection and analysis were performed using custom-
ized digital image acquisition software (Scion, MD). An
apoptotic index for each zone was calculated as: (number
of TUNEL-positive cells/number of DAPI positive cells×100).
Each drill hole was treated as an independent specimen,
and a value for each ‘Zone’ of each specimen was recorded
as the mean of measurements from three separate near-
adjacent sections.
In control animals, the frequency of TUNEL-positive
chondrocytes within 1.5 mm of the injury site was
32.5±8.6%. Most of the apoptotic cells were localized to the
superficial and middle layers of articular cartilage. Animals
treated with daily intra-articular injections of Z-VAD-fmk
showed a dramatic decrease in chondrocyte PCD as
measured by TUNEL analysis (Fig. 1). In the treated
specimens, the overall frequency of chondrocyte PCD
within 1.5 mm of the injury site was reduced to 7.4±1.8%.
The most pronounced effect of Z-VAD-fmk treatment was
noted in Zone 3 (1–1.5 mm from the injury site) where
only 1% of chondrocytes was TUNEL-positive compared to
33% in the untreated group (Fig. 2). To our knowledge,
these experiments are the first to demonstrate the in vivo
effectiveness of intra-articular caspase inhibition on limiting
chondrocyte PCD following acute osteochondral injury.
To validate the results of TUNEL analysis in this
experimental system, immunohistochemistry using an anti-
single-stranded DNA (ssDNA) antibody with formamide–
heat treatment was conducted (Fig. 1, panel E). This
technique has been demonstrated to be highly specific, and
it identifies apoptotic cells independent of DNA fragmen-
tation8. In brief, sections were permeabilized with saponin
followed by digestion with proteinase K. Slides were then
incubated in 50% formamide (20 min at 56–60°C). The
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primary antibody, F7–26 anti-ssDNA (Chemicon, CA), was
applied at 1:10 dilution for 30 min at room temperature.
Biotinylated anti-mouse IgM secondary antibody was
applied, and staining was completed using the Vectastain
ABC kit (Vector Laboratories, CA) following the supplied
protocol. The magnitude and distribution of positive cells
were similar to results observed with TUNEL analysis.
For histological analysis, representative sections were
stained with hematoxylin and eosin (H&E) and safranin-O/
fast green. Histological grading for cartilage degeneration
was performed based on structure, cellularity, and
safranin-O stain distribution as described by Mankin and
co-workers9. Of note, analysis of tidemark integrity was
excluded from the scale due to lack of applicability to the
current model. Some limited chondrocyte loss as defined
by empty lacunae and mild proteoglycan loss as measured
by safranin-O staining were noted in both treated
and untreated specimens. However, using the modified
Mankin grading scale, no statistically significant difference
in histological scores was observed between treated
and untreated specimens four days following injury
[treated=1.5±0.5; controls=1.6±0.5; P0.67 by Mann–
Whitney analysis].
Caspase inhibitors have been shown to reduce levels
of chondrocyte apoptosis following experimental injury
in vitro4,10. Lee et al. reported significant inhibition of levels
of camptothecin-induced apoptosis in human chondrocytes
with the use of selective inhibitors of caspases 3 and 76.
Fig. 1. Representative cartilage sections after TUNEL analysis (A and B) and DAPI staining (C and D). Control specimens are shown on the
left (A and C), and Z-VAD-fmk treated specimens are shown on the right (B and D). Arrows indicate the experimental injury sites. TUNEL
analysis demonstrates decreased levels of PCD in the treated specimen compared to control. The inhibitory effect is more pronounced
moving away from the site of injury. (E) Immunohistochemistry using anti-ssDNA staining of heat/formamide treated specimens to confirm
PCD. Positive cells show dark brown nuclear staining; negative cells show only light blue-green nuclear staining from the counterstain.
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Similarly, Nutall et al. reported diminished levels of apopto-
sis in human chondrocytes treated with Z-VAD-fmk and a
caspase 3-selective inhibitor7. In human cartilage explants
subjected to mechanical loading, D’Lima et al. reported a
34% prevalence of apoptotic chondrocytes and a 50%
reduction with the use of Z-VAD-fmk four days following
injury in vitro10. Pelletier and colleagues demonstrated that
systemic administration of L-NIL, an inhibitor of inducible
nitric oxide synthetase, decreased chondrocyte apoptosis
and cartilage degeneration in a canine model of osteo-
arthritis11. However, we are unaware of any previous
reports demonstrating the in vivo effectiveness of caspase
inhibition in limiting chondrocyte PCD following acute
osteochondral injury.
Previous studies have suggested that diffusible
mediators may play an important role in chondrocyte apop-
tosis following mechanical injury in cartilage12,13. There-
fore, intervention designed to blunt the effects of these
diffusible agents may promote chondrocyte survival in
areas away from the actual site of cartilage injury. This
hypothesis is supported by our finding that caspase inhibi-
tor treatment has a particularly potent effect in limiting PCD
in areas of cartilage slightly away from the site of injury. In
fact, PCD was reduced essentially to background levels in
areas beyond 1 mm from the edge of the drill hole. In areas
of cartilage within 1 mm of the drill hole, it is likely that some
cells either undergo necrotic cell death or are somehow
beyond the ability to be rescued by caspase inhibition due
to overwhelming pro-apoptotic signals. Therefore, it is not
surprising that caspase inhibition has a less of an effect on
PCD in areas of cartilage closer to the site of injury.
The dramatic reduction of chondrocyte PCD observed
after intra-articular administration of a broad-spectrum cas-
pase inhibitor has major clinical significance. Given the
limited intrinsic repair capacity of hyaline cartilage, preser-
vation of existing chondrocytes following articular cartilage
injury may play a particularly important role in optimizing
patient outcomes after joint trauma. The presented data
demonstrate that intra-articular delivery of caspase inhibi-
tors is technically feasible and has the major advantage
of delivering high local concentrations of these agents
while limiting the total systemic dose to a minimum. This
ability to deliver PCD inhibitors directly to the site of
injury is especially important due to the likelihood of toxicity
Fig. 2. Inhibition of chondrocyte apoptosis in vivo with Z-VAD-fmk treatment four days following osteochondral injury. The percentage of
chondrocytes undergoing PCD was assessed by TUNEL analysis and calculated as: (number TUNEL-positive cells/number DAPI positive
cells×100). The area around the injury site was subdivided into three concentric ‘zones’ for independent analysis. Each zone encompasses
the full thickness of articular cartilage for a defined linear distance from the edge of the injury site (Zone 1=0–0.5 mm; Zone 2=0.5–1.0 mm;
Zone 3=1.0–1.5 mm).
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associated with systemic administration of powerful agents
such as caspase inhibitors. The differential effects of cas-
pase treatment on chondrocytes immediately adjacent to
the injury site compared to chondrocytes greater than
1 mm away suggests that caspase inhibition may play a
key role in limiting the ‘zone of injury’ following cartilage
trauma. Although no differences were noted in the histologi-
cal scores of treated and untreated specimens, it is almost
certain that the time point chosen to evaluate for PCD
inhibition (post-injury day 4) is too early for a meaningful
assessment of cartilage degradation. Additional exper-
iments will be necessary to determine if preservation of
chondrocytes in the short-term will result in long-term
preservation of articular cartilage.
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